0000899243-18-017777.txt : 20180622 0000899243-18-017777.hdr.sgml : 20180622 20180622185533 ACCESSION NUMBER: 0000899243-18-017777 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180622 FILED AS OF DATE: 20180622 DATE AS OF CHANGE: 20180622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huh Hoyoung CENTRAL INDEX KEY: 0001401267 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38533 FILM NUMBER: 18915617 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 201 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eidos Therapeutics, Inc. CENTRAL INDEX KEY: 0001731831 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463733671 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-391-9740 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-22 0 0001731831 Eidos Therapeutics, Inc. EIDX 0001401267 Huh Hoyoung C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 1 0 0 0 Stock Option (right to buy) 17.00 2018-06-22 4 A 0 83720 0.00 A 2028-06-21 Common Stock 83720 83750 D The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 83,720 stock options (the "Grant") on June 22, 2018 (the "Grant Date"). The Grant shall vest as follows: one-third of the stock options shall vest annually over a period of three (3) years following the Grant Date subject to the Reporting Person's continued service to the Issuer through each vesting date /s/ Franco Valle, Attorney-in-Fact 2018-06-22